Crossmark

Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised placebo controlled clinical investigation

Crossref DOI link: https://doi.org/10.1186/s40795-025-01153-8

Published Online: 2025-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rondanelli, Mariangela

Perna, Simone

Porta, Matteo Della

Lombardoni, Federico

Patelli, Zaira

Nichetti, Mara

Gasparri, Clara

Pistolesi, Elvira

Cestaro, Benvenuto

Cazzola, Roberta
License Information

Text and Data Mining valid from 2025-09-02

Version of Record valid from 2025-09-02
More Information

Article History

Received: 18 November 2024

Accepted: 5 August 2025

First Online: 2 September 2025

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Bioethical Committee of the IRCCS San Matteo hospital, Pavia (protocol number: 15012020). Informed consent was obtained from all subjects involved in the study.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below